BSE filing, NSE: CESC. Summary written from the filing by ALFA Finder's alert engine.
CESC Ltd: key numbers
- Share price
- ₹126.25
- Market cap
- ₹16,735 Cr
- Revenue (annual)
- ₹18,570 Cr
- Net profit (annual)
- ₹1,542 Cr
- P/E (TTM)
- 10.8×Sector 21.9×
- Promoter holding
- 52.11%+0.00% QoQ
- FII holding
- 11.49%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from CESC Ltd
All →CESC Investor Presentation: Key Takeaways
Q2 FY27 consolidated revenue ₹5,686 Cr (+6%), EBITDA flat at ₹1,217 Cr, PAT ₹438 Cr (-2%). Acquiring 1.4 GWp ReNew solar portfolio at ₹4,859 Cr EV, targeting 10 GW renewables.
CESC Q2 FY27 Results: Net Profit ₹438 Cr, Down 2.2% YoY
CESC Ltd reported revenue from operations of ₹5,607 Cr (+6.5% YoY) and net profit of ₹438 Cr (-2.2% YoY) for Q2 FY27.
- Key figure
- Net profit ₹438 Cr · -2.2% YoY
CESC Acquisition Worth ₹4,859 Cr
CESC revised the completion timeline for acquiring six ReNew renewable entities to November 21, 2026. The deal covers 1.4 GWp capacity at Rs 4,859 crore enterprise value.
- Value
- ₹4,859 Cr
- operational renewable power capacity acquired
- 1411.48 MWp
CESC Board Meeting Date
CESC Ltd scheduled its Board Meeting for 5 Nov 2026 to consider Q2/H1 FY27 unaudited results. No financial figures or decisions are reported in this advance intimation.
CESC Other Announcement
CESC Ltd has submitted its shareholding pattern for the quarter ended September 30, 2026, in compliance with SEBI regulatory requirements.
CESC Other Announcement
This is a routine compliance filing submitting the quarterly certificate under Regulation 74(5) regarding dematerialization activity for the period ended September 30, 2026.
Other annual report announcements
All →Generic Engineering Construction and Projects Annual Report
Generic Engineering filed its FY2025-26 Annual Report ahead of its 32nd AGM on 30 November 2026. The filing covers board changes and a planned bank-funded EPC expansion.
Vineet Laboratories Annual Report
Vineet Laboratories filed its FY 2025-26 Annual Report, which marks its turnaround and recapitalisation year. The AGM is scheduled for 30 November 2026.
Indrayani Biotech Annual Report
Indrayani Biotech has filed its 34th Annual Report for FY2025-26, containing the AGM notice for 30 November 2026 by VC/OAVM. The chairman notes a Rights Issue was initiated in October 2026 to raise capital.
ESDS Software Solution Annual Report
ESDS Software Solution submitted its FY2025-26 Annual Report along with the AGM notice. The AGM is on 30 November 2026 via VC/OAVM, with remote e-voting.
The Orissa Minerals Development Company Annual Report
Orissa Minerals Development Company filed its FY 2025-26 Annual Report and 108th AGM notice, with the AGM set for 30 November 2026. The filing is a Regulation 34 intimation with no transaction or financial event.
Viksit Engineering Annual Report
Viksit Engineering filed its 44th Annual Report for FY 2025-26 with BSE. The report includes notice of the AGM on 30 November 2026.